Matthew Gage
Director of Finance/CFO at PRECIPIO, INC.
Network origin in Matthew Gage first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Medical/Nursing Services | 21 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Matthew Gage via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
DIANON Systems, Inc.
DIANON Systems, Inc. Medical/Nursing ServicesHealth Services Dianon Systems, Inc. provides anatomic pathology, genetic, and clinical chemistry testing services. The firm offers services in uropathology, dermatopathology, gastrointestinal pathology, hematopathology, and breast pathology. The company was founded in 1983 and is headquartered in Stratford, CT. | Medical/Nursing Services | Chief Executive Officer Director of Finance/CFO | |
Athena Neurosciences LLC
Athena Neurosciences LLC Miscellaneous Commercial ServicesCommercial Services Athena Neurosciences LLC operates as a research-based pharmaceutical company committed to the field of neurology. It develops therapeutic and diagnostic products. The company was founded by David Rowley-Jones, Larry C. Fritz, and Larry A. Bock in 1986 and is headquartered in Allegan, MI. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Blueprint Genetics, Inc.
Blueprint Genetics, Inc. Miscellaneous Commercial ServicesCommercial Services Athena Diagnostics, Inc. provides clinical diagnostics testing laboratory services. The firm focuses on neurology, endocrinology, hearing loss and nephrology. It offers tests for Alzheimer's disease, muscular dystrophy and other neuromuscular and developmental disorders. The company was founded in 1988 and is headquartered in Marlborough, MA. | Miscellaneous Commercial Services | Sales & Marketing | |
QuatRx Pharmaceuticals Co.
QuatRx Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology QuatRx Pharmaceuticals Co. manufactures and develops therapeutic compounds. Its clinical products, ospemifene and fispemifene, treat hormone deficiencies that result from aging in women and men. The firm's preclinical program is designed to address sex steroid dependent diseases through inhibition of 17beta- hydroxysteroid dehydrogenase (HSD) enzymes. The company was founded by Robert Zerbe, Christopher Nicholas, and Stuart Dombey on November 20 2000 and is headquartered in Ann Arbor, MI. | Pharmaceuticals: Major | Director/Board Member | |
Cardiac Dimensions, Inc.
Cardiac Dimensions, Inc. Medical SpecialtiesHealth Technology Cardiac Dimensions, Inc. develops novel interventional tools for the treatment of heart failure and the related condition of mitral valve regurgitation. It offers the CARILLON Mitral Contour System, a proprietary and implantable device designed to be positioned in the coronary sinus vein using cardiac catheterization techniques. The firm also offers patient enrollment, clinical testing, and medical consulting services. The company was founded by James W. Fitzsimmons and Scott Jordan Wolf in 2001 and is headquartered in Kirkland, WA. | Medical Specialties | Director/Board Member | |
Magnolia Broadband, Inc.
Magnolia Broadband, Inc. SemiconductorsElectronic Technology Magnolia Broadband, Inc. develops semiconductors for the wireless industry. It offers software, signal processing technologies, and integrated circuit solutions. The company was founded by Haim Harel in 2008 and is headquartered in Englewood, NJ. | Semiconductors | Sales & Marketing | |
BG MEDICINE, INC. | Medical Specialties | Corporate Officer/Principal | |
Weavr Health Corp.
Weavr Health Corp. Medical DistributorsDistribution Services Boston MicroFluidics, Inc. manufactures medical devices. Its product is designed to measure, prepare, and transport blood samples. The company was founded in 2005 and is headquartered in Boston, MA. | Medical Distributors | Director/Board Member | |
Precipio Diagnostics LLC
Precipio Diagnostics LLC Medical/Nursing ServicesHealth Services Precipio Diagnostics LLC operates as a cancer diagnostics reference laboratory. It offers its customers community oncologists and hospitals access to academic institutions and has combined academic-level excellence with the sales and marketing expertise, the proper operational processes and the necessary service level standards required to deliver proper support. The company was founded by Ilan Danieli in 2011 and is headquartered in New Haven, CT. | Medical/Nursing Services | Director/Board Member Chairman Chairman Director of Finance/CFO Director/Board Member Founder Director/Board Member Founder Founder Director/Board Member Director/Board Member Director/Board Member | |
TRANSLATE BIO, INC. | Biotechnology | Director/Board Member | |
OXFORD IMMUNOTEC GLOBAL PLC | Medical Specialties | Director/Board Member Chairman | |
Prostate Management Diagnostics, Inc.
Prostate Management Diagnostics, Inc. BiotechnologyHealth Technology Prostate Management Diagnostics, Inc. engages in the provision of research and test of fluid-based screening tool to identify patients at risk of prostate cancer. It performs research on a series of genetic markers that could determine whether a prostrate cancer is indolent or aggressive in patients newly diagnosed with the disease. The company was founded by Christopher B. Ehrlich and Douglas C. Fisher in 2014 and is headquartered in Sausalito, CA. | Biotechnology | Founder | |
Potenza Therapeutics, Inc.
Potenza Therapeutics, Inc. BiotechnologyHealth Technology Potenza Therapeutics, Inc. develops oncology programs and mechanisms for tumors detection. It is focusing on the discovery and development of novel immune-oncology therapeutics: molecules that stimulate the power of the immune system to fight cancer. The company was founded by Drew M. Pardoll and Daniel J. Hicklin in 2014 and is headquartered in Cambridge, MA. | Biotechnology | Corporate Officer/Principal | |
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal | |
MERRIMACK PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Arsenal Capital Management LP
Arsenal Capital Management LP Investment ManagersFinance Arsenal Capital Management LP (Arsenal Capital) is a private equity subsidiary of Arsenal Capital Group LLC founded in 2000 by Terrence M. Mullen and Jeffrey B. Kovach. The firm is headquartered in New York. | Investment Managers | Consultant / Advisor | |
InterWest Partners LLC
InterWest Partners LLC Investment ManagersFinance InterWest Partners LLC (InterWest Partners) is a venture capital firm founded in 1979 by Wally Hawley, Scott Hedrick and Gene Barth. The firm is headquartered in San Francisco, California. | Investment Managers | Private Equity Investor | |
Miami University | College/University | Undergraduate Degree | |
Oxford Immunotec Ltd.
Oxford Immunotec Ltd. Medical SpecialtiesHealth Technology Oxford Immunotec Ltd. operates as a medical diagnostic company. It develops and sells medical diagnostic products. The company was founded by Peter Wrighton-Smith in 2002 and is headquartered in Abingdon, the United Kingdom. | Medical Specialties | Director/Board Member Chairman | |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
Bar-Ilan University | College/University | Undergraduate Degree | |
New Leaf Venture Partners LLC
New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Venture Partners LLC (New Leaf Ventures) is an independent Venture Capital firm founded by Jeani Delagardelle, Philippe Chambon, Vijay Lathi, Ron Hunt, James Niedel, and Kathy LaPorte. The firm is headquartered in New York. It spun out from Sprout Group. | Investment Managers | Founder Private Equity Analyst | |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Director/Board Member | |
Roche Molecular Systems, Inc.
Roche Molecular Systems, Inc. Medical/Nursing ServicesHealth Services Roche Molecular Systems, Inc. develops and produces molecular-based diagnostic tests and automated testing platforms. It specializes in oncology, virology, microbiology and blood screening tests areas. The firm's customers include researchers, physicians, patients, hospitals, laboratories and blood banks. The company is headquartered in Pleasanton, CA. | Medical/Nursing Services | Sales & Marketing | |
Critical Path Institute
Critical Path Institute Miscellaneous Commercial ServicesCommercial Services Critical Path Institute is a nonprofit organization established in 2005 as a public and private partnership with the FDA's Critical Path Initiative program. The non-profit company is based in Tucson, AZ, and operates from Ireland with additional staff in multiple other locations. The company's mission is to catalyze the development of new approaches that advance medical innovation and regulatory science, accelerating the path to a healthier world. The company orchestrates the development of drug development tools through an innovative, collaborative approach to the sharing of data and expertise, and accelerate the pace and reduce the costs of medical product development by building consensus among the participating institutions. The company was founded in 2005 by Raymond L. Woosley, Glenn C. Rice. Daniel M. Jorgensen has been the CEO of the company since 2022. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
OSIRIS CORPORATION | Trucks/Construction/Farm Machinery | Chief Operating Officer | |
Harvard Medical School | College/University | Corporate Officer/Principal | |
Personalized Medicine Coalition
Personalized Medicine Coalition Miscellaneous Commercial ServicesCommercial Services The Personalized Medicine Coalition promotes the understanding and adoption of personalized medicine concepts, services, and products. The private company is based in Washington and was founded by Patrick F. Terry. | Miscellaneous Commercial Services | Director/Board Member | |
Quest Diagnostics TB LLC
Quest Diagnostics TB LLC Medical SpecialtiesHealth Technology Quest Diagnostics TB LLC develops and sells clinical diagnostic products. It focused on developing proprietary tests for the management of immune-regulated conditions. The company was founded by Dr. Peter Wrighton-Smith in 2002 and is headquartered in Malborough, MA. | Medical Specialties | Director/Board Member Director/Board Member | |
MiraDx, Inc.
MiraDx, Inc. Medical/Nursing ServicesHealth Services MiraDx, Inc. provides research and testing for cancer treatments. It offers radiogenomics and cancer chemotherapy. The company was founded by Joanne B. Weidhaas and Frank Slack in February 2008 and is headquartered in Los Angeles, CA. | Medical/Nursing Services | Corporate Officer/Principal | |
Association for Molecular Pathology
Association for Molecular Pathology BiotechnologyHealth Technology The Association for Molecular Pathology develops molecular diagnostics. The American company was founded by Jeffrey Cossman. | Biotechnology | Founder | |
Halcyon Diagnostics, Inc. | Founder | ||
Perelman School of Medicine | College/University | Doctorate Degree | |
Stanford University School of Medicine | College/University | Doctorate Degree | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
University of Virginia Darden School of Business | College/University | Masters Business Admin | |
Harvard College | College/University | Undergraduate Degree Undergraduate Degree | |
PMV PHARMACEUTICALS, INC. | Miscellaneous Commercial Services | Director/Board Member | |
IDP Holdings LLC
IDP Holdings LLC Financial ConglomeratesFinance IDP Holdings LLC is an investment holding joint venture company. The company is based in New York, NY. | Financial Conglomerates | Corporate Officer/Principal | |
Imagine Scientific, Inc.
Imagine Scientific, Inc. Electronic Equipment/InstrumentsElectronic Technology Imagine Scientific, Inc. develops diagnostic breast imaging using low dose monochromatic x-ray technology. The private company is based in Norwood, MA. The company was founded by Eric Silver. Eric Silver has been the CEO since incorporation. | Electronic Equipment/Instruments | Director/Board Member | |
Revelation Partners LLC
Revelation Partners LLC Investment ManagersFinance Revelation Partners LLC (Revelation Partners) is a venture capital firm founded in 2013. The firm is headquartered in San Francisco, California. | Investment Managers | Private Equity Investor | |
Weavr Health | Director/Board Member | ||
IDRx, Inc.
IDRx, Inc. Miscellaneous Commercial ServicesCommercial Services IDRx, Inc. is a clinical-stage biopharmaceutical company located in an undisclosed location. The American company is dedicated to transforming cancer care with intelligently designed precision therapies. IDRx aims to address the limitations of today's precision cancer medicines with highly potent and selective targeted therapies to stop key tumor escape mechanisms and prolong response to therapy. The company's pipeline programs include small molecule tyrosine kinase inhibitors, and idrx-73, designed to inhibit key genetic drivers and drug-resistant mutations of gastrointestinal stromal tumor (GIST). IDRx was founded in 2021 by Alexis A. Borisy, Nicholas B. Lydon, Ben Auspitz, George D. Demetri, and Robert M. Forrester. Ben Auspitz has been the CEO since incorporation. | Miscellaneous Commercial Services | Founder |
Statistics
International
United States | 48 |
United Kingdom | 3 |
Israel | 2 |
Sectoral
Health Technology | 16 |
Consumer Services | 9 |
Commercial Services | 8 |
Finance | 8 |
Health Services | 7 |
Operational
Director/Board Member | 120 |
Corporate Officer/Principal | 54 |
Independent Dir/Board Member | 30 |
Chairman | 23 |
Founder | 20 |
Most connected contacts
Insiders | |
---|---|
Kathy LaPorte | 34 |
David Cohen | 27 |
Ronald Andrews | 27 |
Douglas Fisher | 25 |
Richard Sandberg | 23 |
Samuel Riccitelli | 15 |
Michael Allen Luther | 14 |
Jeffrey Cossman | 13 |
Robert M. Patzig | 13 |
George Demetri | 12 |
Christina Valauri | 11 |
Ilan Danieli | 9 |
Carl Iberger | 9 |
Ori Karev | 8 |
Stephen R. Miller | 7 |
- Stock Market
- Insiders
- Matthew Gage
- Company connections